{
  "disease_name": "Guanidinoacetate methyltransferase deficiency",
  "orpha_code": "382",
  "drugs": [
    {
      "name": "Adeno-associated vector expressing human codon-optimized guanidinoacetate N-methyltransferase under a ubiquitous-expressing promoter",
      "substance_url": "/en/drug/substance/695313?name=382&mode=orpha&region=&status=all",
      "substance_id": "695313",
      "regulatory_url": "/en/drug/regulatory/695442?name=382&mode=orpha&region=",
      "regulatory_id": "695442",
      "orpha_substance_code": "ORPHA:382",
      "details": [
        "Adeno-associated vector expressing human codon-optimized guanidinoacetate N-methyltransferase under a ubiquitous-expressing promoter(Medicinal product                        - 18/02/2025)Disease(s) concernedORPHA:382 Guanidinoacetate methyltransferase deficiency",
        "Adeno-associated vector expressing human codon-optimized guanidinoacetate N-methyltransferase under a ubiquitous-expressing promoter(Medicinal product                        - 18/02/2025)",
        "(Medicinal product                        - 18/02/2025)",
        "Disease(s) concernedORPHA:382 Guanidinoacetate methyltransferase deficiency",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/695313?name=382&mode=orpha&region=&status=all",
          "text": "Adeno-associated vector expressing human codon-optimized guanidinoacetate N-methyltransferase under a ubiquitous-expressing promoter",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/382",
          "text": "ORPHA:382 Guanidinoacetate methyltransferase deficiency",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/695442?name=382&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Dodecyl creatine ester, dodecyl creatine ester hydrochloride",
      "substance_url": "/en/drug/substance/627137?name=382&mode=orpha&region=&status=all",
      "substance_id": "627137",
      "regulatory_url": "/en/drug/regulatory/627139?name=382&mode=orpha&region=",
      "regulatory_id": "627139",
      "orpha_substance_code": "ORPHA:79172",
      "details": [
        "Dodecyl creatine ester, dodecyl creatine ester hydrochloride(Medicinal product                        - 19/02/2021)Disease(s) concernedORPHA:79172 Creatine deficiency syndrome",
        "Dodecyl creatine ester, dodecyl creatine ester hydrochloride(Medicinal product                        - 19/02/2021)",
        "(Medicinal product                        - 19/02/2021)",
        "Disease(s) concernedORPHA:79172 Creatine deficiency syndrome",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/627137?name=382&mode=orpha&region=&status=all",
          "text": "Dodecyl creatine ester, dodecyl creatine ester hydrochloride",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79172",
          "text": "ORPHA:79172 Creatine deficiency syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/627139?name=382&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Cyclocreatine",
      "substance_url": "/en/drug/substance/480188?name=382&mode=orpha&region=&status=all",
      "substance_id": "480188",
      "regulatory_url": "/en/drug/regulatory/480190?name=382&mode=orpha&region=",
      "regulatory_id": "480190",
      "orpha_substance_code": "ORPHA:79172",
      "details": [
        "Cyclocreatine(Medicinal product                        - 27/06/2016)Disease(s) concernedORPHA:79172 Creatine deficiency syndrome",
        "Cyclocreatine(Medicinal product                        - 27/06/2016)",
        "(Medicinal product                        - 27/06/2016)",
        "Disease(s) concernedORPHA:79172 Creatine deficiency syndrome",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/480188?name=382&mode=orpha&region=&status=all",
          "text": "Cyclocreatine",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79172",
          "text": "ORPHA:79172 Creatine deficiency syndrome",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/480190?name=382&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "More details on the regulatory status",
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T06:03:21.845202",
  "run_number": 1,
  "total_drugs_found": 3,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=Guanidinoacetate+methyltransferase+deficiency&orphaCode=382&name=382&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "Guanidinoacetate methyltransferase deficiency",
    "orphaCode": "382",
    "name": "382",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}